Search details
1.
Focal high-intensity focused ultrasound therapy for localized prostate cancer: An interim analysis of the multinational FASST study.
Eur J Clin Invest
; 54(6): e14192, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38445798
2.
The Prognostic Association of Prostate MRI PI-RADS™ v2 Assessment Category and Risk of Biochemical Recurrence after Definitive Local Therapy for Prostate Cancer: A Systematic Review and Meta-Analysis.
J Urol
; 206(3): 507-516, 2021 Sep.
Article
in English
| MEDLINE | ID: mdl-33904755
3.
The role of taxane-based chemotherapy in the treatment of prostate cancer.
Curr Opin Urol
; 30(4): 527-533, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32453003
4.
An up-to-date catalogue of urinary markers for the management of prostate cancer.
Curr Opin Urol
; 30(5): 684-688, 2020 09.
Article
in English
| MEDLINE | ID: mdl-32701725
5.
Clinical parameters for the prediction of occult lymph node metastasis in patients with negative PSMA-PET.
Urol Oncol
; 42(4): 115.e9-115.e16, 2024 04.
Article
in English
| MEDLINE | ID: mdl-38246806
6.
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters.
Eur Urol Oncol
; 7(2): 231-240, 2024 Apr.
Article
in English
| MEDLINE | ID: mdl-37689506
7.
Dual-Tracer PET-MRI-Derived Imaging Biomarkers for Prediction of Clinically Significant Prostate Cancer.
Curr Oncol
; 30(2): 1683-1691, 2023 01 30.
Article
in English
| MEDLINE | ID: mdl-36826090
8.
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool.
Eur Urol Oncol
; 6(6): 543-552, 2023 12.
Article
in English
| MEDLINE | ID: mdl-37270378
9.
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study.
Eur Urol Oncol
; 2023 Oct 14.
Article
in English
| MEDLINE | ID: mdl-37845121
10.
Accuracy of SelectMDx compared to mpMRI in the diagnosis of prostate cancer: a systematic review and diagnostic meta-analysis.
Prostate Cancer Prostatic Dis
; 25(2): 187-198, 2022 02.
Article
in English
| MEDLINE | ID: mdl-35414118
11.
Reliability of Serial Prostate Magnetic Resonance Imaging to Detect Prostate Cancer Progression During Active Surveillance: A Systematic Review and Meta-analysis.
Eur Urol
; 80(5): 549-563, 2021 11.
Article
in English
| MEDLINE | ID: mdl-34020828
12.
Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy.
J Pers Med
; 11(11)2021 Nov 19.
Article
in English
| MEDLINE | ID: mdl-34834583
13.
Clinical Impact and Statistical Significance of Multiparametric Magnetic Resonance Imaging for Local Staging of Prostate Cancer.
Eur Urol
; 79(2): 186-187, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33246667
14.
Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer.
Eur Urol
; 77(1): 132-133, 2020 01.
Article
in English
| MEDLINE | ID: mdl-31542306
Results
1 -
14
de 14
1
Next >
>>